Joe Horrigan (Neuren’s Vice President, Clinical Development and Medical Affairs) has joined AMO Pharma as Chief Medical Officer. I assume this means Joe has left Neuren, and I am hoping it is because he has seen the writing on the wall…that Neuren will be acquired within the next 6 months so he might as well lock in a gig somewhere else.
http://www.prnewswire.com/news-rele...harma-as-chief-medical-officer-300252278.html
Joe Horrigan (Neuren’s Vice President, Clinical Development and...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6044 | $15.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 1411 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |